167 related articles for article (PubMed ID: 18165851)
1. Imaging, subjective complaints, and MCI: 30 years before.
Galluzzi S; Frisoni GB
J Nutr Health Aging; 2008 Jan; 12(1):80S-3S. PubMed ID: 18165851
[TBL] [Abstract][Full Text] [Related]
2. Brain-imaging surrogate markers for detection and prevention of age-related memory loss.
Small GW
J Mol Neurosci; 2002; 19(1-2):17-21. PubMed ID: 12212776
[TBL] [Abstract][Full Text] [Related]
3. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
4. Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer's disease.
Small GW
Adv Drug Deliv Rev; 2002 Dec; 54(12):1561-6. PubMed ID: 12453673
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of (11)C-Pittsburgh compound-B positron emission tomography carried out in addition to magnetic resonance imaging and single-photon emission computed tomography on the diagnosis of Alzheimer's disease in patients with dementia and mild cognitive impairment.
Omachi Y; Ito K; Arima K; Matsuda H; Nakata Y; Sakata M; Sato N; Nakagome K; Motohashi N
Psychiatry Clin Neurosci; 2015 Dec; 69(12):741-51. PubMed ID: 26085054
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
[TBL] [Abstract][Full Text] [Related]
7. Polygenic hazard score: an enrichment marker for Alzheimer's associated amyloid and tau deposition.
Tan CH; Fan CC; Mormino EC; Sugrue LP; Broce IJ; Hess CP; Dillon WP; Bonham LW; Yokoyama JS; Karch CM; Brewer JB; Rabinovici GD; Miller BL; Schellenberg GD; Kauppi K; Feldman HA; Holland D; McEvoy LK; Hyman BT; Bennett DA; Andreassen OA; Dale AM; Desikan RS;
Acta Neuropathol; 2018 Jan; 135(1):85-93. PubMed ID: 29177679
[TBL] [Abstract][Full Text] [Related]
8. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
[TBL] [Abstract][Full Text] [Related]
9. Functional imaging in mild cognitive impairment and early Alzheimer's disease: is it pertinent?
Ibáñez V; Deiber MP
Front Neurol Neurosci; 2009; 24():30-38. PubMed ID: 19182460
[TBL] [Abstract][Full Text] [Related]
10. What does imaging add to the management of Alzheimer's disease?
Small GW
CNS Spectr; 2004 Jul; 9(7 Suppl 5):20-3. PubMed ID: 15241296
[TBL] [Abstract][Full Text] [Related]
11. Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment.
Barrio JR; Kepe V; Satyamurthy N; Huang SC; Small G
J Nutr Health Aging; 2008 Jan; 12(1):61S-5S. PubMed ID: 18165848
[TBL] [Abstract][Full Text] [Related]
12. Neuropathological changes in aging brain.
Xekardaki A; Kövari E; Gold G; Papadimitropoulou A; Giacobini E; Herrmann F; Giannakopoulos P; Bouras C
Adv Exp Med Biol; 2015; 821():11-7. PubMed ID: 25416106
[TBL] [Abstract][Full Text] [Related]
13. In vivo quantification of neurofibrillary tangles with [
Pascoal TA; Shin M; Kang MS; Chamoun M; Chartrand D; Mathotaarachchi S; Bennacef I; Therriault J; Ng KP; Hopewell R; Bouhachi R; Hsiao HH; Benedet AL; Soucy JP; Massarweh G; Gauthier S; Rosa-Neto P
Alzheimers Res Ther; 2018 Jul; 10(1):74. PubMed ID: 30064520
[TBL] [Abstract][Full Text] [Related]
14. A review on Alzheimer's disease classification from normal controls and mild cognitive impairment using structural MR images.
Garg N; Choudhry MS; Bodade RM
J Neurosci Methods; 2023 Jan; 384():109745. PubMed ID: 36395961
[TBL] [Abstract][Full Text] [Related]
15. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia.
Lowe VJ; Wiste HJ; Senjem ML; Weigand SD; Therneau TM; Boeve BF; Josephs KA; Fang P; Pandey MK; Murray ME; Kantarci K; Jones DT; Vemuri P; Graff-Radford J; Schwarz CG; Machulda MM; Mielke MM; Roberts RO; Knopman DS; Petersen RC; Jack CR
Brain; 2018 Jan; 141(1):271-287. PubMed ID: 29228201
[TBL] [Abstract][Full Text] [Related]
16. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
[TBL] [Abstract][Full Text] [Related]
17. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
Swerdlow RH
Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and prognosis of Alzheimer's disease using brain morphometry and white matter connectomes.
Wang Y; Xu C; Park JH; Lee S; Stern Y; Yoo S; Kim JH; Kim HS; Cha J;
Neuroimage Clin; 2019; 23():101859. PubMed ID: 31150957
[TBL] [Abstract][Full Text] [Related]
19. Associations between quantitative [
Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
[TBL] [Abstract][Full Text] [Related]
20. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
Grundman M; Petersen RC; Ferris SH; Thomas RG; Aisen PS; Bennett DA; Foster NL; Jack CR; Galasko DR; Doody R; Kaye J; Sano M; Mohs R; Gauthier S; Kim HT; Jin S; Schultz AN; Schafer K; Mulnard R; van Dyck CH; Mintzer J; Zamrini EY; Cahn-Weiner D; Thal LJ;
Arch Neurol; 2004 Jan; 61(1):59-66. PubMed ID: 14732621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]